BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND LMNA, EMD2, 4000, ENSG00000160789, LGMD1B, LDP1, PRO1, LMNC, FPLD, CDDC, HGPS, P02545, LFP, IDC, CMD1A, CDCD1, LMN1, CMT2B1, FPL AND Diagnosis
15 results:

  • 1. Differential Plasma Proteins Identified via iTRAQ-Based Analysis Serve as Diagnostic Markers of pancreatic Ductal Adenocarcinoma.
    Chen X; Liao X; Zheng B; Wang F; Chen F; Deng Z; Jiang H; Qin S
    Dis Markers; 2023; 2023():5145152. PubMed ID: 36712921
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Predicting pancreatic ductal adenocarcinoma using artificial intelligence analysis of pre-diagnostic computed tomography images.
    Qureshi TA; Gaddam S; Wachsman AM; Wang L; Azab L; Asadpour V; Chen W; Xie Y; Wu B; Pandol SJ; Li D
    Cancer Biomark; 2022; 33(2):211-217. PubMed ID: 35213359
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Elevation in creatine kinase isoenzyme-MM associated with hepatocellular carcinoma: a case report and review of literature.
    Nakamura Y; Ito K; Takemura N; Inagaki F; Mihara F; Kokudo N
    Clin J Gastroenterol; 2022 Apr; 15(2):460-466. PubMed ID: 35199319
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: a year-long, population-level analysis.
    Peacock HM; Tambuyzer T; Verdoodt F; Calay F; Poirel HA; De Schutter H; Francart J; Van Damme N; Van Eycken L
    ESMO Open; 2021 Aug; 6(4):100197. PubMed ID: 34474811
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Invasive Ductal Carcinoma Arising in Mucinous Cystic Neoplasm of Pancreas: A Case Report.
    Sawai H; Kurimoto M; Koide S; Kiriyama Y; Haba S; Matsuo Y; Morimoto M; Koide H; Kamiya A; Yamao K
    Am J Case Rep; 2019 Feb; 20():242-247. PubMed ID: 30798329
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Predictive value of drain amylase content for peripancreatic inflammatory fluid collections after laparoscopic (assisted) distal gastrectomy.
    Kanda M; Fujiwara M; Tanaka C; Kobayashi D; Iwata N; Mizuno A; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Kodera Y
    Surg Endosc; 2016 Oct; 30(10):4353-62. PubMed ID: 26857580
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Mass spectrometry cleavable strategy for identification and differentiation of prenylated peptides.
    Bhawal RP; Sadananda SC; Bugarin A; Laposa B; Chowdhury SM
    Anal Chem; 2015 Feb; 87(4):2178-86. PubMed ID: 25616024
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Biphasic Alterations in Expression and Subcellular Localization of MUC1 in pancreatic Ductal Carcinogenesis in Syrian Hamsters.
    Kitahashi T; Takahashi M; Imai T
    Pancreas; 2015 Jan; 44(1):76-86. PubMed ID: 25036908
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Review article: enzyme supplementation in cystic fibrosis, chronic pancreatitis, pancreatic and periampullary cancer.
    Imrie CW; Connett G; Hall RI; Charnley RM
    Aliment Pharmacol Ther; 2010 Nov; 32 Suppl 1():1-25. PubMed ID: 21054452
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. IgG4+ to IgG+ plasma cells ratio of ampulla can help differentiate autoimmune pancreatitis from other "mass forming" pancreatic lesions.
    Sepehr A; Mino-Kenudson M; Ogawa F; Brugge WR; Deshpande V; Lauwers GY
    Am J Surg Pathol; 2008 Dec; 32(12):1770-9. PubMed ID: 18779730
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Quantitative analysis of MUC1 and MUC5AC mRNA in pancreatic juice for preoperative diagnosis of pancreatic cancer.
    Ohuchida K; Mizumoto K; Yamada D; Fujii K; Ishikawa N; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    Int J Cancer; 2006 Jan; 118(2):405-11. PubMed ID: 16052519
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas.
    Saitou M; Goto M; Horinouchi M; Tamada S; Nagata K; Hamada T; Osako M; Takao S; Batra SK; Aikou T; Imai K; Yonezawa S
    J Clin Pathol; 2005 Aug; 58(8):845-52. PubMed ID: 16049287
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. DOTA-lanreotide: a novel somatostatin analog for tumor diagnosis and therapy.
    Smith-Jones PM; Bischof C; Leimer M; Gludovacz D; Angelberger P; Pangerl T; Peck-Radosavljevic M; Hamilton G; Kaserer K; Kofler A; Schlangbauer-Wadl H; Traub T; Virgolini I
    Endocrinology; 1999 Nov; 140(11):5136-48. PubMed ID: 10537142
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Congenital pancreatoblastoma in Beckwith-Wiedemann syndrome: an emerging association.
    Drut R; Jones MC
    Pediatr Pathol; 1988; 8(3):331-9. PubMed ID: 2845376
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group.
    Moertel CG; Frytak S; Hahn RG; O'Connell MJ; Reitemeier RJ; Rubin J; Schutt AJ; Weiland LH; Childs DS; Holbrook MA; Lavin PT; Livstone E; Spiro H; Knowlton A; Kalser M; Barkin J; Lessner H; Mann-Kaplan R; Ramming K; Douglas HO; Thomas P; Nave H; Bateman J; Lokich J; Brooks J; Chaffey J; Corson JM; Zamcheck N; Novak JW
    Cancer; 1981 Oct; 48(8):1705-10. PubMed ID: 7284971
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.